StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) stock

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)

Close on Nov 17, 2026Market cap $50.42MP/E –Yield –

Tonix Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Tonix Pharmaceuticals's total debt was $7.49M at Dec 31, 2024. For fiscal 2024 it was $7.49M, down 16.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$7.49M-16.0%
FY2023Dec 31, 2023$8.91M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$7.49M-16.0%
Q3 FY2024Sep 30, 2024$7.99M–
Q2 FY2024Jun 30, 2024$8.49M–
Q1 FY2024Mar 31, 2024$8.98M–
Q4 FY2023Dec 31, 2023$8.91M–

More Tonix Pharmaceuticals figures

See a number that looks wrong?